AbbVie Inc. (ABBV)
ABBV price $282.42 -2.38 -0.84%
- Ticker
- ABBV
- Price
- $282.42
- Change
- -2.38 -0.84%
- Market cap
- $499.07B
- P/E
- 80.21
- Forward P/E
- 20.29
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 56
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in…